does tirzepatide work vs. Semaglutide: What You Should Know Tirzepatide vs. Retatrutide: Key Differences

Patients aged40 years, diagnosed with type 2 diabetes, having stable non-insulin GLA use, and without NAFLD/NASH history were included

Taking Ozempic or another GLP-1

Semaglutide, originally approved for diabetes treatment, has become a groundbreaking weight loss medication, offering significant results with an average 14.9% body weight reduction in clinical trials, though its high cost has led to increased interest in more affordable compounded versions, which should be obtained from reputable sources under proper medical supervision.

New Data: Phase 3 TRIUMPH-4 Results (Retatrutide) Eli Lilly just released topline results from the Phase 3 TRIUMPH-4 trial, evaluating the triple hormone receptor agonist retatrutide in patients with obesity and knee osteoarthritis (OA)

Tara Narula breaks down new research suggesting GLP-1 medications may be linked to a lower risk of breast cancer diagnoses.